89 related articles for article (PubMed ID: 17201135)
1. Expression of interleukin-17 in human colorectal cancer.
Wägsäter D; Löfgren S; Hugander A; Dimberg J
Anticancer Res; 2006; 26(6B):4213-6. PubMed ID: 17201135
[TBL] [Abstract][Full Text] [Related]
2. Analysis of single nucleotide polymorphism in the promoter and protein expression of the chemokine eotaxin-1 in colorectal cancer patients.
Wågsäter D; Löfgren S; Hugander A; Dienus O; Dimberg J
World J Surg Oncol; 2007 Jul; 5():84. PubMed ID: 17672898
[TBL] [Abstract][Full Text] [Related]
3. Expression and gene polymorphisms of the chemokine CXCL5 in colorectal cancer patients.
Dimberg J; Dienus O; Löfgren S; Hugander A; Wågsäter D
Int J Oncol; 2007 Jul; 31(1):97-102. PubMed ID: 17549409
[TBL] [Abstract][Full Text] [Related]
4. Decreased expression of the chemokine CCL21 in human colorectal adenocarcinomas.
Mumtaz M; Wågsäter D; Löfgren S; Hugander A; Zar N; Dimberg J
Oncol Rep; 2009 Jan; 21(1):153-8. PubMed ID: 19082456
[TBL] [Abstract][Full Text] [Related]
5. Protein expression of the chemokine, CCL28, in human colorectal cancer.
Dimberg J; Hugander A; Wågsäter D
Int J Oncol; 2006 Feb; 28(2):315-9. PubMed ID: 16391784
[TBL] [Abstract][Full Text] [Related]
6. Interleukin-6 level in patients with colorectal cancer.
Esfandi F; Mohammadzadeh Ghobadloo S; Basati G
Cancer Lett; 2006 Nov; 244(1):76-8. PubMed ID: 16442710
[TBL] [Abstract][Full Text] [Related]
7. The association of interleukin-16 polymorphisms with IL-16 serum levels and risk of colorectal and gastric cancer.
Gao LB; Rao L; Wang YY; Liang WB; Li C; Xue H; Zhou B; Sun H; Li Y; Lv ML; Du XJ; Zhang L
Carcinogenesis; 2009 Feb; 30(2):295-9. PubMed ID: 19073878
[TBL] [Abstract][Full Text] [Related]
8. Resistin in human colorectal cancer: increased expression independently of resistin promoter -420C > G genotype.
Wågsater D; Mumtaz M; Lofgren S; Hugander A; Dimberg J
Cancer Invest; 2008 Dec; 26(10):1008-14. PubMed ID: 18798067
[TBL] [Abstract][Full Text] [Related]
9. Clinical significance of tissue expression of interleukin-6 in colorectal carcinoma.
Chung YC; Chaen YL; Hsu CP
Anticancer Res; 2006; 26(5B):3905-11. PubMed ID: 17094421
[TBL] [Abstract][Full Text] [Related]
10. Human neutrophil peptides 1, 2 and 3 are biochemical markers for metastatic colorectal cancer.
Albrethsen J; Møller CH; Olsen J; Raskov H; Gammeltoft S
Eur J Cancer; 2006 Nov; 42(17):3057-64. PubMed ID: 17015013
[TBL] [Abstract][Full Text] [Related]
11. Expression of chemokine receptor CXCR6 in human colorectal adenocarcinomas.
Wågsäter D; Dimberg J
Anticancer Res; 2004; 24(6):3711-4. PubMed ID: 15736401
[TBL] [Abstract][Full Text] [Related]
12. Expression of CD137 and CD137 ligand in colorectal cancer patients.
Dimberg J; Hugander A; Wågsäter D
Oncol Rep; 2006 May; 15(5):1197-200. PubMed ID: 16596186
[TBL] [Abstract][Full Text] [Related]
13. Overexpression of soluble vascular endothelial growth factor receptor 1 in colorectal cancer: Association with progression and prognosis.
Yamaguchi T; Bando H; Mori T; Takahashi K; Matsumoto H; Yasutome M; Weich H; Toi M
Cancer Sci; 2007 Mar; 98(3):405-10. PubMed ID: 17214745
[TBL] [Abstract][Full Text] [Related]
14. [Growth hormone receptor expression in human colorectal cancer and its implication].
Yang XD; Liu FK; Xu Z; Li JS
Zhonghua Wei Chang Wai Ke Za Zhi; 2005 May; 8(3):252-4. PubMed ID: 16167241
[TBL] [Abstract][Full Text] [Related]
15. Clinical significance of plasma level of vascular endothelial growth factor-C in patients with colorectal cancer.
Miyazaki T; Okada N; Ishibashi K; Ogata K; Ohsawa T; Ishiguro T; Nakada H; Yokoyama M; Matsuki M; Kato H; Kuwano H; Ishida H
Jpn J Clin Oncol; 2008 Dec; 38(12):839-43. PubMed ID: 18923001
[TBL] [Abstract][Full Text] [Related]
16. Expression of heat shock protein 70 (HSP70) in patients with colorectal adenocarcinoma--immunohistochemistry and Western blot analysis.
Milićević ZT; Petković MZ; Drndarević NC; Pavlović MD; Todorović VN
Neoplasma; 2007; 54(1):37-45. PubMed ID: 17233550
[TBL] [Abstract][Full Text] [Related]
17. Human leukocyte antigen-E protein is overexpressed in primary human colorectal cancer.
Levy EM; Bianchini M; Von Euw EM; Barrio MM; Bravo AI; Furman D; Domenichini E; Macagno C; Pinsky V; Zucchini C; Valvassori L; Mordoh J
Int J Oncol; 2008 Mar; 32(3):633-41. PubMed ID: 18292941
[TBL] [Abstract][Full Text] [Related]
18. Prognostic value of plasma D-dimer levels in patients with colorectal cancer.
Kilic M; Yoldas O; Keskek M; Ertan T; Tez M; Gocmen E; Koc M
Colorectal Dis; 2008 Mar; 10(3):238-41. PubMed ID: 17868411
[TBL] [Abstract][Full Text] [Related]
19. Occurrence of hematogenous metastasis and serum levels of thymidine phosphorylase in colorectal cancer.
Haraguchi M; Komuta K; Akashi A; Furui J; Kanematsu T
Oncol Rep; 2003; 10(5):1207-12. PubMed ID: 12883682
[TBL] [Abstract][Full Text] [Related]
20. Identification of CD8+CD25+Foxp3+ suppressive T cells in colorectal cancer tissue.
Chaput N; Louafi S; Bardier A; Charlotte F; Vaillant JC; Ménégaux F; Rosenzwajg M; Lemoine F; Klatzmann D; Taieb J
Gut; 2009 Apr; 58(4):520-9. PubMed ID: 19022917
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
